Document is current
Any future updates will be listed below
-
Authors
Weber, Brittany
Merola, Joseph F.
Husni, M. Elaine
Di Carli, Marcelo
Berger, Jeffrey S.
Garshick, Michael S.
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32 HL094301.)
National Institutes of Health (R35HL144993)
National Institutes of Health (R01HL139909)
National Institutes of Health (K23 HL152013)
National Psoriasis Foundation (Bridge Grant)
American Heart Association (18CDA34080540)
- License Information
-
More Information
Article History
Accepted: 26 July 2021
First Online: 1 September 2021
Compliance with Ethical Standards
:
: Brittany Weber has nothing to disclose. Joseph F. Merola reports personal fees from Abbvie, Amgen, Bayer, Lilly, Novartis, Janssen, Celgene, Biogen, Pfizer, and BMS; and other from UCB, Sanofi, Dermavant, and Leo. M. Elaine Husni reports grants from the Pfizer cardiovascular biomarker sub-study. Marcelo Di Carli reports grants from Gilead Sciences and Spectrum Dynamics. Jeffrey Berger reports personal fees from Janssen Pharmaceuticals Inc. and Amgen. Michael S. Garshick reports grants from Pfizer and personal fees from Abbvie.
: All procedures performed by the authors of this review in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
